Calamos Advisors
BCRX icon

Calamos Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Calamos Advisors’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-103,359
Closed -$1.68M – 1122
2022
Q1 		$1.68M Buy
+103,359
New +$1.68M 0.01% 927